Back to home
CRL logo

Is CRL (Charles River Laboratories International, Inc.) Halal or Haram?

New York Stock ExchangeHealthcareMedical - Diagnostics & Research$8.10B2026-04-29
CRL is Doubtful3/4 screens passed

While Charles River Laboratories' core business in medical research and diagnostics is permissible, the stock currently fails AAOIFI financial screens due to excessive leverage. Specifically, its debt-to-market cap ratio stands at 37.8%, exceeding the strict 33% threshold, making the stock Doubtful for Muslim investors despite acceptable interest income (0.12%) and cash levels (2.6%).

Price Chart (5D)

$183.98-0.21 (-0.11%)
2026-06-082026-05-29

CRL — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-06-08182.80184.00182.80183.7010K+0.49%
2026-06-05187.18187.35180.55181.34519K-3.12%
2026-06-04182.00187.95180.60185.79737K+2.08%
2026-06-03172.75181.05169.46179.87536K+4.12%
2026-06-02179.00181.76172.17174.79752K-2.35%
2026-06-01180.28184.68178.06182.07996K+0.99%
2026-05-29181.34184.83177.01180.711.0M-0.35%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for CRL

Business Activity

Permissible

Charles River Laboratories passes the business activity screen as its core operations in drug discovery, safety testing, and providing rodent research models are permissible under Islamic finance principles.

Debt / Market Cap

37.83%

Debt: $3.07BThreshold: ≤33%

Interest Income

0.12%

Interest: $4.9MThreshold: ≤5%

Cash & Securities

2.64%

Cash: $213.8MThreshold: ≤33%

About Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. operates as a leading non-clinical contract research organization supporting drug discovery and safety testing worldwide. The company provides critical services for pharmaceutical development, including the production of specialized rodent research models used extensively by medical researchers.

For Muslim investors using AAOIFI standards, CRL is currently classified as Doubtful. While the underlying medical research business is perfectly halal, the stock fails the financial screening criteria due to high leverage, meaning it does not currently align with strict Islamic investment guidelines.

The primary concern from an Islamic finance perspective is the company's debt-to-market capitalization ratio, which sits at 37.8%, breaching the 33% maximum limit. On a positive note, its interest-bearing cash and securities represent only 2.6% of its market cap, and interest income is negligible at 0.12% of total revenue.

Halal investors should monitor CRL's balance sheet in upcoming quarters. If the company actively reduces its debt burden or if its market capitalization increases sufficiently to bring the debt ratio below the 33% threshold, the stock could become fully compliant.

CEO

James C. Foster

Employees

18,700

IPO Date

2000-06-23

Headquarters

Wilmington, MA, US

CRL Key Financial Statistics

Revenue

$4.02B

Net Income

$-144.3M

EPS (Diluted)

$-2.91

Stock Price

164.25

Beta

1.62

52-Week Range

113.89-228.88

Total Debt

$3.07B

Total Equity

$3.16B

Current Ratio

1.29

CRL Financial Health & Profitability

Profit Margins

Gross Margin30.5%
Operating Margin12.6%
Net Margin-3.6%

Revenue Growth (YoY)

-0.9%

Prior year: $4.05B

Net Debt

$2.85B

Cash: $213.8M — Debt: $3.07B

Frequently Asked Questions About CRL

Is CRL (Charles River Laboratories International, Inc.) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, CRL is classified as Doubtful. It passed 3 of 4 compliance screens. Some scholars may permit investing with income purification, while others advise avoiding it. We recommend consulting a qualified Islamic scholar before investing in CRL.
What does Charles River Laboratories International, Inc. do?
Charles River Laboratories International, Inc. operates as a leading non-clinical contract research organization supporting drug discovery and safety testing worldwide. The company provides critical services for pharmaceutical development, including the production of specialized rodent research models used extensively by medical researchers. For Muslim investors using AAOIFI standards, CRL is currently classified as Doubtful. While the underlying medical research business is perfectly halal, the stock fails the financial screening criteria due to high leverage, meaning it does not currently align with strict Islamic investment guidelines. The primary concern from an Islamic finance perspective is the company's debt-to-market capitalization ratio, which sits at 37.8%, breaching the 33% maximum limit. On a positive note, its interest-bearing cash and securities represent only 2.6% of its market cap, and interest income is negligible at 0.12% of total revenue. Halal investors should monitor CRL's balance sheet in upcoming quarters. If the company actively reduces its debt burden or if its market capitalization increases sufficiently to bring the debt ratio below the 33% threshold, the stock could become fully compliant. Charles River Laboratories International, Inc. operates in the Healthcare sector under the Medical - Diagnostics & Research industry and is headquartered in Wilmington, MA, US. The company is led by CEO James C. Foster and employs approximately 18,700 people.
What screening criteria were used for CRL?
CRL was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. CRL passed 3 of these 4 screens.
When was CRL last screened?
CRL was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for CRL (Charles River Laboratories International, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Screened Stocks in Healthcare